1. Last 7 days
    1. https://www.youtube.com/watch?v=dX-Aq7pRrag&list=PLX_ensLRxEWCxj7kABujGRcvTPFRfBiQj&index=4

      Résumé de la vidéo [00:00:00][^1^][1] - [00:24:12][^2^][2] : Cette vidéo présente une analyse comparative de la notion de méritocratie, en se concentrant sur l'évolution historique et les pratiques actuelles en Chine. Pierre-Michel Menger explore le concept de mérite à travers l'éducation, les réformes gouvernementales et les stratégies familiales, en soulignant l'impact des investissements parentaux et des choix éducatifs sur les opportunités des enfants.

      Points forts : + [00:00:23][^3^][3] La méritocratie en Chine * Discussion sur l'éducation et le mérite en Chine impériale et contemporaine * Exemple d'un CV détaillé d'un enfant pour une école primaire privée * L'importance des efforts et des talents individuels versus les investissements familiaux + [00:05:59][^4^][4] Les examens impériaux * Les examens impériaux comme moyen de sélection des talents pour le service de l'État * Débat sur la mobilité sociale et l'accès à l'éducation * La transition de la Chine impériale à la République et les réformes éducatives + [00:14:28][^5^][5] L'éducation après la Révolution culturelle * Les changements dans l'éducation pendant et après la Révolution culturelle * L'accent sur la démocratisation de l'éducation primaire et la lutte contre l'analphabétisme * La tension entre être "rouge" (politiquement favorable) et être un expert + [00:21:49][^6^][6] Stratégies familiales contemporaines * Les stratégies des familles chinoises pour naviguer dans le système éducatif * La pression parentale pour assurer le succès éducatif des enfants * La régulation gouvernementale des services éducatifs parascolaires Résumé de la vidéo [00:24:14][^1^][1] - [00:39:55][^2^][2]:

      Cette partie de la vidéo aborde la notion de méritocratie dans le contexte éducatif chinois, en examinant les différentes stratégies que les familles utilisent pour accéder aux meilleures écoles. L'orateur discute des méthodes telles que les loteries d'État, les recommandations, les cours préparatoires, et l'achat d'appartements basés sur la carte scolaire. Il souligne les inégalités et les tensions sociales qui en découlent, notamment en ce qui concerne l'accès aux ressources éducatives et la perception du mérite.

      Points forts: + [00:24:14][^3^][3] Les méthodes d'admission * Loteries d'État, recommandations, et cours préparatoires * Corruption et connexions personnelles * Stratégies résidentielles pour accéder aux écoles + [00:27:01][^4^][4] Financement des écoles * Manque de financement, surtout dans les zones rurales * Cours parascolaires pour compléter le budget * Budgets alternatifs et leur impact + [00:30:01][^5^][5] Stratégies des familles * Distinction entre classes moyennes supérieures et inférieures * Diversité de stratégies basées sur les ressources financières * Tensions sociales et perception de la justice éducative + [00:34:00][^6^][6] Cas de l'école Teency * Conflit entre les enfants migrants et l'école d'élite * Séparation physique et réactions des parents * Débat sur la justice et le mérite dans l'accès à l'éducation

    1. https://www.youtube.com/watch?v=HqzgnTiEjCw&list=PLX_ensLRxEWCxj7kABujGRcvTPFRfBiQj&index=5

      Résumé de la vidéo [00:00:00][^1^][1] - [00:25:05][^2^][2] : La vidéo présente une conférence de Pierre-Michel Menger sur la méritocratie, en se concentrant sur la Silicon Valley comme un cas d'étude. Il explore les origines historiques de la méritocratie aux États-Unis, la dialectique de la Silicon Valley et les contradictions entre les aspirations progressistes et les inerties socio-économiques.

      Points forts : + [00:00:58][^3^][3] La méritocratie aux États-Unis * La terre d'élection de la méritocratie * Contraste avec l'Angleterre et ses critiques * Influence de Max Weber sur l'idée de mérite + [00:03:19][^4^][4] La Silicon Valley comme élite sans classe * Valorisation du travail et diversité cosmopolite * Opposition aux institutions traditionnelles * Mentalité centrée sur la liberté et l'innovation + [00:07:08][^5^][5] Double standard sociologique * Disparités entre entrepreneurs ordinaires et 'super entrepreneurs' * Inégalités de genre, d'âge et d'origine ethnique * Prédominance des diplômés de grandes universités américaines + [00:14:07][^6^][6] Le succès dans la Silicon Valley * Civilité et familiarité dans les relations professionnelles * Histoire du venture capitalisme et l'importance de l'humain * La Silicon Valley comme société centrée sur l'individu + [00:21:53][^7^][7] La notion de mérite versus récompense * Glissement de la notion de mérite vers celle de récompense * L'innovation technologique liée à des innovations financières et managériales * La Silicon Valley tournée vers l'avenir et les nouvelles technologies Résumé de la vidéo [00:25:07][^1^][1] - [00:32:03][^2^][2]:

      Cette partie de la vidéo aborde la « méritocratie » dans le contexte de la Silicon Valley, en mettant l'accent sur les pratiques managériales et les stratégies d'entreprise qui brouillent les frontières entre travail et capital, loisirs et travail, ainsi que l'intérêt privé et le bien public.

      Points forts: + [00:25:07][^3^][3] L'importance de l'entrée en Bourse * Transforme le travail en capital * Permet le contrôle de Wall Street sur les entreprises de la Silicon Valley + [00:26:10][^4^][4] Les pratiques managériales temporelles * Valorisation des loisirs pour fidéliser les travailleurs * Création d'espaces de loisirs et de temps libre pour la créativité + [00:27:53][^5^][5] Les 20% de temps libre chez Google * Les employés travaillent sur leurs propres projets * Tout ce qui est créé est contrôlé et capitalisé par l'entreprise + [00:28:35][^6^][6] La dimension morale des entreprises * Les entreprises véhiculent des valeurs et des missions * Ces éléments servent de motivation et de récompense morale pour les salariés

    1. https://www.youtube.com/watch?v=kGgi8AN2FeM&list=PLX_ensLRxEWCxj7kABujGRcvTPFRfBiQj&index=6

      Résumé de la vidéo [00:00:00][^1^][1] - [00:25:23][^2^][2]:

      Cette vidéo présente une conférence de Pierre-Michel Menger sur la méritocratie, en se concentrant sur le recrutement des hauts fonctionnaires en France. Il explore l'histoire et les débats autour de la méritocratie, les citations clés, et les définitions du mérite, tout en partageant son expérience personnelle en tant que praticien dans le domaine de la haute fonction publique.

      Points forts: + [00:00:49][^3^][3] La méritocratie dans le recrutement * Définition et histoire de la méritocratie * Citations de Hippolyte Carnot et Emmanuel Macron * La permanence des débats sur le recrutement des hauts fonctionnaires + [00:04:07][^4^][4] Qu'est-ce que la méritocratie? * Analyse étymologique et définitions du mérite * La méritocratie selon Michael Young et ses implications * Le débat sur la justice de récompenser sur la base du mérite + [00:10:12][^5^][5] L'égalité et le mérite selon Nicolas Sarkozy * Distinction entre égalité des chances et égalité des conditions * Le mérite comme effort et travail * La méritocratie et l'élitisme républicain + [00:17:02][^6^][6] Les fonctions de la méritocratie * Légitimation de la hiérarchie dans l'administration * Recrutement de fonctionnaires compétents et efficaces * Indépendance et permanence de l'administration Résumé de la vidéo [00:25:25][^1^][1] - [00:49:11][^2^][2]:

      Cette partie de la vidéo aborde la notion de méritocratie dans le contexte français, en particulier l'indépendance de l'administration et le recrutement des hauts fonctionnaires. L'orateur examine l'histoire de l'administration publique en France, les réformes du Consulat, et les procédures de recrutement au mérite à travers les concours. Il souligne également les défis actuels de la méritocratie, notamment l'endogamie et l'efficacité de l'État.

      Points forts: + [00:25:25][^3^][3] L'indépendance de l'administration * Un trait caractéristique de la France depuis la Révolution française * Controverses historiques sur le rôle et l'autonomie de l'administration + [00:27:00][^4^][4] Les réformes du Consulat * Uniformisation de la rémunération et des critères d'avancement * Création des grands corps de l'État comme le Conseil d'État et la Cour des comptes + [00:28:41][^5^][5] Le recrutement au mérite * Le concours comme procédure centrale de recrutement * Autres procédures complémentaires pour assurer l'ouverture sociale + [00:37:00][^6^][6] La crise de la méritocratie * La perception du mérite comme largement fictif * Les critiques actuelles et les propositions de réforme pour renouveler le recrutement

      Résumé de la vidéo [00:49:13][^1^][1] - [00:50:29][^2^][2]:

      La partie 3 de la vidéo aborde la notion de méritocratie et son lien avec l'université, soulignant le rôle de cette dernière dans la mobilité sociale ascendante et la recherche.

      Points forts: + [00:49:13][^3^][3] Université et mobilité sociale * L'université favorise la mobilité sociale ascendante * Plus efficace que les grandes écoles pour la diversité sociale * En déclin dans les grandes écoles + [00:49:45][^4^][4] Recherche universitaire * La recherche est essentielle face à un monde incertain et complexe * Les méthodes de recherche aident à anticiper les évolutions * La culture de la recherche est un atout majeur + [00:50:13][^5^][5] Université et fonction publique * Un lien étroit entre université et recrutement des fonctionnaires est souhaitable * L'association de la formation et des modalités de recrutement est une utopie souhaitable * Applaudissements et musique concluent la présentation

    1. https://www.youtube.com/watch?v=Y46Z_7pRRz8&list=PLX_ensLRxEWCxj7kABujGRcvTPFRfBiQj&index=9

      Résumé de la vidéo [00:00:00][^1^][1] - [00:12:49][^2^][2]:

      Cette vidéo présente une conférence de Pierre-Michel Menger sur la méritocratie, offrant une perspective comparative et abordant les tensions entre les intérêts individuels et collectifs, la compétition, et les principes d'équité et d'efficacité.

      Points forts: + [00:00:23][^3^][3] Conclusion sur la méritocratie * La fierté nationale et les accomplissements individuels * La tension entre les intérêts personnels et collectifs * L'impact de la compétition sur les comportements stratégiques + [00:02:53][^4^][4] Comparaison spatiale et historique * L'importance de la comparaison géographique et culturelle * La persistance historique et l'évolution des mécanismes sociaux * L'exemple de la Chine et de la France dans le contexte de la méritocratie + [00:05:09][^5^][5] Mérite et interaction stratégique * Le mérite n'est pas un champ de paix perpétuel * Les mécanismes de rareté des ressources et la compétition * L'univers familial comme site de transmission et d'altruisme + [00:07:33][^6^][6] Équilibre entre équité et efficacité * La tension entre les objectifs d'équité et d'efficacité * Le pluralisme et la diversité comme solutions potentielles * La nécessité d'assurer un socle minimal de besoins pour tous

    1. https://www.youtube.com/watch?v=TJC1X6qj7aM&list=PLX_ensLRxEWCxj7kABujGRcvTPFRfBiQj&index=8

      Résumé de la vidéo [00:00:00][^1^][1] - [00:23:38][^2^][2] : La vidéo présente une conférence de Pierre-Michel Menger sur la méritocratie, analysant son paradoxe en tant que principe de justice sociale largement accepté mais souvent critiqué dans le milieu universitaire. Il explore les fondements philosophiques et les critiques de la méritocratie, proposant des justifications pour sa défense.

      Points forts : + [00:00:22][^3^][3] Le paradoxe de la méritocratie * Vue comme fondamentale pour la justice sociale * Populaire dans la société, mais rejetée par les universitaires * Changement d'attitude depuis le 19e siècle + [00:02:18][^4^][4] Critiques de la méritocratie * Considérée comme un préjugé sans justification essentielle * Jugée caduque dans les sociétés modernes et les marchés * Potentiellement dangereuse si utilisée comme seul principe moral + [00:04:06][^5^][5] Justifications du mérite * Popularité du mérite comme justification philosophique * Mérite comme principe d'efficacité et d'incitation * Organisation des motivations privées et publiques * Communication morale à travers le mérite + [00:09:01][^6^][6] Popularité internationale du mérite * Enquêtes démontrant l'ancrage profond du mérite dans diverses sociétés * Consensus international sur l'importance du mérite * Mérite considéré comme un principe fondamental de justice Résumé de la vidéo [00:23:40][^1^][1] - [00:33:26][^2^][2] : La vidéo présente une analyse approfondie de la méritocratie, en examinant les justifications instrumentales et fondamentales du mérite, ainsi que son rôle dans l'harmonisation des motivations personnelles et publiques. Elle explore également comment le mérite peut servir de communication morale dans la société et l'importance de reconnaître divers mérites basés sur différentes contributions.

      Points saillants : + [00:23:40][^3^][3] Justifications du mérite * Critique des justifications instrumentales * Nécessité de justifications fondamentales * Mérite défini par la contribution + [00:24:09][^4^][4] Harmonisation des motivations * Mérite comme moyen d'aligner les intérêts personnels et publics * Légitimité des motivations personnelles et altruistes * Récompense du mérite encourageant la contribution au bien public + [00:26:27][^5^][5] Conflit de motivations * Exemple historique de conflit entre motivations intéressées et altruistes * Injustice des systèmes qui forcent ce conflit * Importance d'un système équitable récompensant le mérite + [00:28:34][^6^][6] Communication morale et reconnaissance * Le mérite comme moyen de valoriser les actions * Importance de la reconnaissance des diverses contributions * Luttes sociales pour la reconnaissance du mérite + [00:31:22][^7^][7] Conséquences politiques de la méritocratie * Mérite comme socle moral universel * Acceptation des inégalités justifiées par la contribution * Harmonisation du mérite avec d'autres valeurs sociales

    1. https://www.youtube.com/watch?v=ftfZ8n87xwc&list=PLX_ensLRxEWCxj7kABujGRcvTPFRfBiQj&index=7

      Résumé de la vidéo [00:00:00][^1^][1] - [00:25:35][^2^][2]:

      Cette vidéo présente une conférence de Pierre-Michel Menger sur la méritocratie, en se concentrant sur le rôle du talent dans l'innovation et la connaissance. Menger explore si le talent est nécessaire pour innover, si une partie de ce talent est perdue et ce que l'on peut faire à ce sujet. Il définit le talent comme la capacité à résoudre des problèmes complexes pendant l'adolescence et discute de l'importance de l'entraînement et de l'effort dans le développement du talent.

      Points forts: + [00:00:22][^3^][3] Introduction et questions clés * Présentation de la recherche sur le talent et l'innovation * Trois questions principales sur le talent, la perte de talent et les actions possibles + [00:01:19][^4^][4] Définition et importance du talent * Le talent comme capacité à résoudre des problèmes complexes * L'importance de l'entraînement et de l'effort dans le développement du talent + [00:02:26][^5^][5] Anecdote sur Grégory Perelman * L'histoire de Perelman et sa résolution de la conjecture de Poincaré * Discussion sur la fréquence des découvertes faites par des personnes talentueuses + [00:07:24][^6^][6] Lien entre les Olympiades de mathématiques et les récompenses académiques * Corrélation entre la participation aux Olympiades et l'obtention de la médaille Fields * Statistiques sur la probabilité de gagner une médaille Fields en fonction de la performance aux Olympiades + [00:11:14][^7^][7] Le talent perdu à l'intérieur des pays * La tendance des inventeurs à provenir de milieux favorisés * L'hypothèse du "Lost Einstein" et la perte de talents potentiels + [00:16:24][^8^][8] Différences d'opportunités entre les pays * L'impact du pays de naissance sur les chances de devenir un producteur de connaissances * La nécessité d'améliorer les opportunités pour les jeunes talentueux de milieux défavorisés

    1. mais en fait la critique de Michael sandle c'est que le système 00:25:28 méritocratique bon lui parle des États-Unis mais ça se transpose très bien à d'autres pays comme la France ce système méritocratique est essentiellement scolaire valorise une classe éduquée celle qui dit possède les 00:25:40 diplômes de la evilique par exemple qui est arrogante et qui croit qui attribue son sa situation sociale sa position prééminente dans la société à son talent personnel donc qui justifierait son statut et son salaire élevé et en 00:25:54 contrepartie ça humilie ce qui se trouve en bas de la hiérarchie sociale et qui ce qui non seulement sont frustrés objectivement par leur position de vie mais en plus sont obligés par cette justification méritocratique de 60 sans 00:26:06 sentir responsable et donc de se sentir de se voir eux-mêmes comme étant non méritant et stupide c'est pas moi qui le dis c'est c'est Michael sandle
    1. Once you have your own fresh eggs, you’ll never want store eggs again.

      He's right. I've bought a few from local farmer's markets. The eggshells are usually thicker and they do indeed taste better, more natural for lack of a better word.

    2. We’ve been buying baby chicks by U.S. mail from Murray McMurray Hatchery for 30-plus years. We’ll get a call from the postmaster, sometimes a bit flustered, because there’s a box there with peeping chicks awaiting pick-up. We’ll go get them and set them up with a light and feed and water, and lo and behold in three months we’ll have laying hens. Minimum order is 25, so the chicks can warm each other in transit.

      Absolutely nuts -- I had no idea one could order baby chicks in the mail.

    1. Patients often prefer to see a doctor with whom theycan identify.10 Although there are approximately 40 millionBlacks (13% of the population) in the United States, only 5%of physicians and 2.9% of ophthalmologists are Black—andthe disparity is even greater for non-White Hispanics.11Even more challenging, of the 2,400 retina specialists inthe United States, fewer than 100 are an underrepresentedminority. We desperately need stronger efforts to enrollmore underrepresented minorities into medical school, assistwith matriculation into competitive residencies and fellow-ships, expose students to subspecialty societies, and encour-age early participation in advisory boards and research.Patient DistrustLong-standing social injustices and prejudices have ledto skepticism among people of color regarding healthcare. Numerous research abuses, such as the TuskegeeSyphilis Study,13 the story of Henrietta Lacks and HeLacells,14 and radiation studies on prisoners, have left deep-seated doubt in the minds of many about the safety andbenefits of research.12 This sentiment persists today, dur-ing the pandemic, as 30% to 50% of minorities distrust theCOVID-19 vaccine and aren’t considering vaccination.15Cost and Time CommitmentOut-of-pocket travel costs, travel time to trial sites, medi-cal follow-up appointments, unexpected bills,16 missing work,and childcare costs are among the concerns that restrictpatients from trial participation. We should make everyeffort to ensure that all study patients have no out-of-pocketexpenses while enrolled in a clinical trial.SOLUTIONS: HOW TO MOVE FORWARDAddress Implicit BiasAs physician investigators, we need to examine ourown biases. In addition, sponsors should have an “unmetneeds” dialogue with principal investigators to explain theimportance of racial and ethnic diversity in trial partici-pants. These dialogues should highlight disparities in dis-ease prevalence, mortality data, and long-term disabilitieswithin underrepresented groups. They should also empha-size that clinical trial recruitment must represent patientswho will eventually, upon approval, be treated with themedication, and that efficacy and side effect data mustreflect all races and ethnicities.Increase Minority Enrollment in Medical SchoolsOnly a few years ago, I was the only African Americanretina specialist in the state of Ohio. In medical school, I wasthe only Black male in my class, and few of my fellow stu-dents and professors were people of color. To find my place, Iquickly learned the value of mentors.This is one of the reasons I strongly endorse initiativessuch as the AAO’s Minority Ophthalmology Mentoring pro-gram.17 We not only need to bring awareness of the field ofophthalmology to the next generation of students, but alsoto create an inclusive environment in which minorities canthrive. As a recipient of the Rabb-Venable Research Awardfrom the National Medical Association,18 I know firsthandthe difference these types of programs can make for a youngmedical professional.Build Equity and TrustRebuilding trust within communities of color requirescommitment from industry sponsors, policymakers, healthcare professionals, and patient advocates, among others.Outreach programs and support groups (eg, in churches andcommunity centers) can help to increase the health literacyof minority patients and reinforce the importance of clinicaltrial participation.Additionally, we must improve the informed consentprocess. Consent forms should be translated into the nativelanguages of community patients and sent home with thepatients for further review. A follow-up call afterward canaddress questions from the patient and family prior to thescreening appointment.Physicians have a responsibility to combat racial bias amongstaff members and colleagues. At my practice, our monthlymeetings include a discussion of clinical trial recruitment strat-egies. It’s important that we train our staff, make clinical studyinformation accessible in exam rooms, and consider locatingclinical trial sites near underserved areas.Collaborate with IndustryIn addition to making an impact in our local communities,we must also focus our attention on the regional and nationallandscape to reduce racial bias in clinical trials. Genentech’sExternal Council on Advancing Inclusive Research, of which I’vebeen a member for more than 2 years, seeks to ensure that trial

      I Highlighted this because I have parents that are grew up in Vietnam so they don't speak English that well. There are not a lot of Vietnamese doctors out to help my parents with their concerns. They some time wish that they have Vietnamese doctors because they share the same culture and beliefs. It some time hard for them to express what their concerns are to a white or other minorities doctors. They want to see a doctors that can speak in Vietnamese to them. This is one of the reason I want to become a nurse so I can speak to patients that are from Vietnam. I want to them to know that there are Vietnamese people out there that works in the healthcare industry and are willing to help them when needed

    2. For example, Black women have a 41% higher mortalityrate from breast cancer compared with White women,1,2 butthey represent only 5% of clinical trial participants.3 Likewise,Black men have a 76% higher incidence rate and 120% higherdeath rate from prostate cancer compared with White men,4yet more than 96% of participants enrolled in these studiesare White.5

      I chose this section because I was quite surprised by the statistics that were provided. Having my grandmother diagnosed with breast cancer this statement hits a soft spot, but more so that race plays a factor in your chances of survival. That is disheartening to even think about.

      This section expressed the value of having quality, affordable, and non-biased healthcare available to all. Many people have created their own judgment based on the care they personally have received. Having equality within the healthcare system is extremely important, especially for groups where it's lacking just that.

      This theme relates to me and my experiences of seeing how people other than white can be treated differently in the healthcare system when it comes down to the availability of appointments, wait times, and just even common courtesy among these establishments. I also am planning to enter into the health field (sonography) and once I do, I will aspire to advocate as well as create equality and fairness among my patients and fellow coworkers.

    1. В свою очередь, Германия лишалась всех колоний и обязывалась уплачивать репарации. Правда, размер выплат не оговаривался: об этом победители в ходе конференции договориться не смогли.

      Омг

    1. they’re helping fill the gap in patient care, which traditional health models sometimes fail to do.

      I wish there was more specific information about what makes it different

    2. Twill (formerly Happify) is one example of using emotion AI in mental healthcare. Its Intelligent Healing platform uses AI to learn about one’s health needs and recommend a course of action. Its health chatbot is trained to provide personalized care and support in an empathetic way.

      how is this diff that regular AI chatbot

    3. Another solution for bias is to develop a truly mobilized product to train the AI—a product that's cheap, accessible and globally distributed so it can cover as many cultural representations as possible.

      what does this really mean?

    4. Bias is another concern for the AI community. If datasets are biased toward a certain type of population, the AI won't be reliable when you extrapolate it out to the larger population.

      right, how can we best choose the training set? using demographics from mental health patients in general?

    5. Technology and computing are developing faster compared to government legislation

      another concern

    6. that if machines understand emotion, they could gain sentience and potentially manipulate our emotions. This is a valid concern, but at the same time, these machines are given a very limited playground to play within.

      what is the balance between limiting the training set and creating the most effective and comprehensive EAI?

    7. Emotion AI allows us to predict what a person's state is with a level of competency that can be as good or even better than what a caregiver could tell us.

      interesting to take on the side of caregivers which seem to be less mentioned in the literature and crucial in a field like mental health

    8. In mental healthcare, this kind of technology has great potential in diagnostics.

      similar to other research i reviewed before

    9. Through their work, they sparked the idea to help machines develop empathy.

      curious how they will define empathy vs other papers ive read

    1. Fit flexible nonlinea

      Ah now Method 5!

    2. Separately for levels

      Method 4

    3. Stratify the sample b

      Method 3 ?

    4. Scatterplot of Y vs.

      this is method 2?

    5. Methods for checking fit:

      Confused ... are you listing several methods? Maybe renumber the 5 methods?? or maybe I am just demonstrating my ignorance ...

      1. Fit simple

      2. Scatterplot of ...

      3. Stratify ...

      4. Separately for ...

      5. Fit flexible nonlinear ...

    6. Stone and Koo Stone & Koo

      Just one reference? So maybe just

      "Stone and Koo (1985)"

      or

      "Stone & Koo (1985)"

    1. GoFundMe: #1 Fundraising Platform for Crowdfunding.

      Gofundme is a crowdsourcing platform where various people can donate to a specific cause that they want to support, and typically there is an overall donation goal. However from what i have seen, the majority of contributions on gofundme are from familiar faces. How would a person market their gofundme to other people that they might know? What would make a person enthusiastic about their cause?

    1. Nearly All of Wikipedia Is Written By Just 1 Percent of Its Editors

      I found this statistic very interesting, because of the amount of content on Wikipedia. This means that on average, the average person in the top 1% of editors on wikipedia have likely written dozens, if not hundreds of articles. What makes someone become one of these users? Same thing with twitter, what makes a person want to post that much?

    1. Copypasta. May 2009. URL

      Copypastas are lines of text that a user can copy and paste, often being humorous or "shitposts". These serve almost no purpose other than being annoying pretty much, and possibly drawing a picture with the text. Why do people enjoy copypastas so much (myself included)? Is there anyway copypastas can be used for good, or are they just annoying to look at?

    1. Donald Trump was banned first from Twitter, then from Facebook, and Facebook announced an end to special treatment for politicians

      This makes me wonder, what is the correlation between social media companies and the government? How much control does the government have over what policies social media platforms have, and over who gets banned. I remember there was a scandal about social media platforms not showing the Hunter Biden story prior to the 2020 election. Is there any reason why some content gets censored even though it doesn't violate any policies?

    1. Digital detox. November 2023.

      I have never heard of digital detox, but I have seen people discussing a dopamine detox. The primary difference between the two is that a dopamine detox also includes anything that triggers your dopamine receptors. This makes me wonder what the benefit of each one is, and whether its better to do one over the other.

    1. someone pretends to have a disease, like cancer, to get sympathy or attention

      This is something I have seen often on the internet. People would self-diagnose themselves with something that they don't actually have. However, it seems like occasionally these people do it intentionally for the sake of having "fun". In other occasions, it feels like the person themselves in a way "convinces" themselves that they have that illness (primarily mental illnesses). Is it possible to actually make yourself believe that you actually have an illness that you origibnally did not have?

    1. These goals are all about doing or chasing something that’s personally meaningful to you. These goals fuel your core needs and wants - who you are as a person. They pertain to your passions, interests, and core values as well as your relationships and your personal growth. * Whenever I work on projects, I am usual quite excited about working on it because it's a project I make into my own which means it starts out with interests I have in mind or builds my interest in the middle of working on the project. Of course, not everything will start out with me being interested but I find that discovering your interests and inspirations help motivate you to endure the long process and working progress of a project. Although, since I lack real life experience, asking references or researching references of types of projects I would be working with, drives my inspiration to make the project reach my stakeholder's goals/interests/standards.

      On side personal projects like songs and videos, I have experienced this determination and discipline to continuously work on a project. Because this project is something I know and want to make a reality, I persevere. Others might called this, passion.

    1. This Mishna seems to be laying out a framework for all of Bava Kama, which is interesting. It's interesting because of the ambition, but the Gemara seems to play along.

    1. In short, it simplifies the web development process. As long as you have a basic knowledge of web dev (JS, HTML etc.) you can make apps that are shareable right away!

      create apps that are shareable right away

  2. agregore.mauve.moe agregore.mauve.moe
    1. A great place to start if you want to create apps using Agregore ✨

      create apps with agregore

    1. RRID:AB_141607

      DOI: 10.1152/ajplung.00135.2023

      Resource: (Molecular Probes Cat# A-21202, RRID:AB_141607)

      Curator: @bandrow

      SciCrunch record: RRID:AB_141607


      What is this?

    2. RRID:AB_2534017

      DOI: 10.1152/ajplung.00135.2023

      Resource: (Thermo Fisher Scientific Cat# A10042, RRID:AB_2534017)

      Curator: @bandrow

      SciCrunch record: RRID:AB_2534017


      What is this?

    1. Bloomington stock center

      DOI: 10.1093/nar/gkad1158

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    2. 58889

      DOI: 10.1093/nar/gkad1158

      Resource: BDSC_58889

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_58889


      What is this?

    3. 41208

      DOI: 10.1093/nar/gkad1158

      Resource: RRID:BDSC_41208

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_41208


      What is this?

    4. 33773

      DOI: 10.1093/nar/gkad1158

      Resource: RRID:BDSC_33773

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_33773


      What is this?

    5. 43642

      DOI: 10.1093/nar/gkad1158

      Resource: (BDSC Cat# 43642,RRID:BDSC_43642)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_43642


      What is this?

    1. Bloomington Drosophila Stock Center

      DOI: 10.1101/2023.08.15.553385

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    2. BDSC 3605

      DOI: 10.1101/2023.08.15.553385

      Resource: (BDSC Cat# 3605,RRID:BDSC_3605)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_3605


      What is this?

    3. BDSC 9755

      DOI: 10.1101/2023.08.15.553385

      Resource: RRID:BDSC_9755

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_9755


      What is this?

    4. BDSC 25211

      DOI: 10.1101/2023.08.15.553385

      Resource: (BDSC Cat# 25211,RRID:BDSC_25211)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_25211


      What is this?

    5. BDSC 92470

      DOI: 10.1101/2023.08.15.553385

      Resource: RRID:BDSC_92470

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_92470


      What is this?

    1. Bloomington Drosophila stock center

      DOI: 10.1101/2023.12.01.569590

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    2. 35785

      DOI: 10.1101/2023.12.01.569590

      Resource: (BDSC Cat# 35785,RRID:BDSC_35785)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_35785


      What is this?

    1. Bloomington Stock Center

      DOI: 10.1101/2023.12.03.569799

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    1. Bloomington Drosophila Stock Center

      DOI: 10.1371/journal.pone.0295412

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    1. Bloomington Drosophila Stock Center

      DOI: 10.1038/s41467-023-43550-2

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    2. 16671

      DOI: 10.1038/s41467-023-43550-2

      Resource: BDSC_16671

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_16671


      What is this?

    3. 9575

      DOI: 10.1038/s41467-023-43550-2

      Resource: (BDSC Cat# 9575,RRID:BDSC_9575)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_9575


      What is this?

    4. 1309

      DOI: 10.1038/s41467-023-43550-2

      Resource: (BDSC Cat# 1309,RRID:BDSC_1309)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_1309


      What is this?

    5. 27656

      DOI: 10.1038/s41467-023-43550-2

      Resource: (BDSC Cat# 27656,RRID:BDSC_27656)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_27656


      What is this?

    1. #41553

      DOI: 10.1039/d3na00684k

      Resource: (BDSC Cat# 41553,RRID:BDSC_41553)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_41553


      What is this?

    2. #6903

      DOI: 10.1039/d3na00684k

      Resource: (BDSC Cat# 6903,RRID:BDSC_6903)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_6903


      What is this?

    3. Bloomington Drosophila Stock

      DOI: 10.1039/d3na00684k

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    1. Strain ID: 000651

      DOI: 10.1016/j.xgen.2024.100545

      Resource: (IMSR Cat# JAX_000651,RRID:IMSR_JAX:000651)

      Curator: @abever99

      SciCrunch record: RRID:IMSR_JAX:000651


      What is this?

    2. 003715

      DOI: 10.1016/j.xgen.2024.100545

      Resource: (IMSR Cat# JAX_003715,RRID:IMSR_JAX:003715)

      Curator: @abever99

      SciCrunch record: RRID:IMSR_JAX:003715


      What is this?

    3. 001145

      DOI: 10.1016/j.xgen.2024.100545

      Resource: (IMSR Cat# JAX_001145,RRID:IMSR_JAX:001145)

      Curator: @abever99

      SciCrunch record: RRID:IMSR_JAX:001145


      What is this?

    4. 000646

      DOI: 10.1016/j.xgen.2024.100545

      Resource: (IMSR Cat# JAX_000646,RRID:IMSR_JAX:000646)

      Curator: @abever99

      SciCrunch record: RRID:IMSR_JAX:000646


      What is this?

    5. 001800

      DOI: 10.1016/j.xgen.2024.100545

      Resource: (IMSR Cat# JAX_001800,RRID:IMSR_JAX:001800)

      Curator: @abever99

      SciCrunch record: RRID:IMSR_JAX:001800


      What is this?

    6. 000928

      DOI: 10.1016/j.xgen.2024.100545

      Resource: (IMSR Cat# JAX_000928,RRID:IMSR_JAX:000928)

      Curator: @abever99

      SciCrunch record: RRID:IMSR_JAX:000928


      What is this?

    7. 000671

      DOI: 10.1016/j.xgen.2024.100545

      Resource: (IMSR Cat# JAX_000671,RRID:IMSR_JAX:000671)

      Curator: @abever99

      SciCrunch record: RRID:IMSR_JAX:000671


      What is this?

    8. 000664

      DOI: 10.1016/j.xgen.2024.100545

      Resource: (IMSR Cat# JAX_000664,RRID:IMSR_JAX:000664)

      Curator: @abever99

      SciCrunch record: RRID:IMSR_JAX:000664


      What is this?

    1. Bloomington Drosophila Stock Center

      DOI: 10.1093/g3journal/jkad277

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    2. BDSC 59967

      DOI: 10.1093/g3journal/jkad277

      Resource: RRID:BDSC_59967

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_59967


      What is this?

    3. BDSC 32203

      DOI: 10.1093/g3journal/jkad277

      Resource: (BDSC Cat# 32203,RRID:BDSC_32203)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_32203


      What is this?

    4. 32079

      DOI: 10.1093/g3journal/jkad277

      Resource: (BDSC Cat# 32079,RRID:BDSC_32079)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_32079


      What is this?

    5. 7415

      DOI: 10.1093/g3journal/jkad277

      Resource: (BDSC Cat# 7415,RRID:BDSC_7415)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_7415


      What is this?

    6. 5138

      DOI: 10.1093/g3journal/jkad277

      Resource: (BDSC Cat# 5138,RRID:BDSC_5138)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_5138


      What is this?

    7. 8816

      DOI: 10.1093/g3journal/jkad277

      Resource: (BDSC Cat# 8816,RRID:BDSC_8816)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_8816


      What is this?

    8. 43343

      DOI: 10.1093/g3journal/jkad277

      Resource: RRID:BDSC_43343

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_43343


      What is this?

    9. 33832

      DOI: 10.1093/g3journal/jkad277

      Resource: (BDSC Cat# 33832,RRID:BDSC_33832)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_33832


      What is this?

    10. 47473

      DOI: 10.1093/g3journal/jkad277

      Resource: RRID:BDSC_47473

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_47473


      What is this?

    11. 30139

      DOI: 10.1093/g3journal/jkad277

      Resource: (BDSC Cat# 30139,RRID:BDSC_30139)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_30139


      What is this?

    12. 30026

      DOI: 10.1093/g3journal/jkad277

      Resource: (BDSC Cat# 30026,RRID:BDSC_30026)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_30026


      What is this?

    13. 25373

      DOI: 10.1093/g3journal/jkad277

      Resource: (BDSC Cat# 25373,RRID:BDSC_25373)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_25373


      What is this?

    14. 5818

      DOI: 10.1093/g3journal/jkad277

      Resource: RRID:BDSC_5818

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_5818


      What is this?

    15. 26160

      DOI: 10.1093/g3journal/jkad277

      Resource: (BDSC Cat# 26160,RRID:BDSC_26160)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_26160


      What is this?

    16. 29968

      DOI: 10.1093/g3journal/jkad277

      Resource: (BDSC Cat# 29968,RRID:BDSC_29968)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_29968


      What is this?

    17. 8860

      DOI: 10.1093/g3journal/jkad277

      Resource: (BDSC Cat# 8860,RRID:BDSC_8860)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_8860


      What is this?

    18. 25750

      DOI: 10.1093/g3journal/jkad277

      Resource: (BDSC Cat# 25750,RRID:BDSC_25750)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_25750


      What is this?

    1. 17-4301-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 17-4301-82, RRID:AB_470178)

      Curator: @abever99

      SciCrunch record: RRID:AB_470178


      What is this?

    2. 12-4301-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 12-4301-82, RRID:AB_470047)

      Curator: @abever99

      SciCrunch record: RRID:AB_470047


      What is this?

    3. 11-4301-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 11-4301-82, RRID:AB_470009)

      Curator: @abever99

      SciCrunch record: RRID:AB_470009


      What is this?

    4. 47-5932-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 47-5932-82, RRID:AB_2573992)

      Curator: @abever99

      SciCrunch record: RRID:AB_2573992


      What is this?

    5. 47-7311-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 47-7311-82, RRID:AB_2688061)

      Curator: @abever99

      SciCrunch record: RRID:AB_2688061


      What is this?

    6. 61-0112-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 61-0112-82, RRID:AB_2574528)

      Curator: @abever99

      SciCrunch record: RRID:AB_2574528


      What is this?

    7. 108452

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (BioLegend Cat# 108451 (also 108452), RRID:AB_2564248)

      Curator: @abever99

      SciCrunch record: RRID:AB_2564248


      What is this?

    8. 115543

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (BioLegend Cat# 115543, RRID:AB_11218994)

      Curator: @abever99

      SciCrunch record: RRID:AB_11218994


      What is this?

    9. 108749

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (BioLegend Cat# 108749, RRID:AB_2564304)

      Curator: @abever99

      SciCrunch record: RRID:AB_2564304


      What is this?

    10. 104732

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (BioLegend Cat# 104732, RRID:AB_2686972)

      Curator: @abever99

      SciCrunch record: RRID:AB_2686972


      What is this?

    11. 115541

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (BioLegend Cat# 115541, RRID:AB_11204087)

      Curator: @abever99

      SciCrunch record: RRID:AB_11204087


      What is this?

    12. 103155

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (BioLegend Cat# 103155, RRID:AB_2650656)

      Curator: @abever99

      SciCrunch record: RRID:AB_2650656


      What is this?

    13. 100548

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (BioLegend Cat# 100548, RRID:AB_2563054)

      Curator: @abever99

      SciCrunch record: RRID:AB_2563054


      What is this?

    14. 48-5320-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 48-5320-82, RRID:AB_10669941)

      Curator: @abever99

      SciCrunch record: RRID:AB_10669941


      What is this?

    15. 48-0902-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 48-0902-82, RRID:AB_1272200)

      Curator: @abever99

      SciCrunch record: RRID:AB_1272200


      What is this?

    16. 45-0081-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 45-0081-82, RRID:AB_1107004)

      Curator: @abever99

      SciCrunch record: RRID:AB_1107004


      What is this?

    17. 45-0051-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 45-0051-82, RRID:AB_914334)

      Curator: @abever99

      SciCrunch record: RRID:AB_914334


      What is this?

    18. 45-0031-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 45-0031-82, RRID:AB_1107000)

      Curator: @abever99

      SciCrunch record: RRID:AB_1107000


      What is this?

    19. 25-0114-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 25-0114-82, RRID:AB_469590)

      Curator: @abever99

      SciCrunch record: RRID:AB_469590


      What is this?

    20. 25-7133-80

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 25-7133-80, RRID:AB_2573529)

      Curator: @abever99

      SciCrunch record: RRID:AB_2573529


      What is this?

    21. 127622

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (BioLegend Cat# 127622, RRID:AB_10643269)

      Curator: @abever99

      SciCrunch record: RRID:AB_10643269


      What is this?

    22. 103128

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (BioLegend Cat# 103128, RRID:AB_493715)

      Curator: @abever99

      SciCrunch record: RRID:AB_493715


      What is this?

    23. 17-1271-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 17-1271-82, RRID:AB_469435)

      Curator: @abever99

      SciCrunch record: RRID:AB_469435


      What is this?

    24. 12-1702-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 12-1702-82, RRID:AB_2637129)

      Curator: @abever99

      SciCrunch record: RRID:AB_2637129


      What is this?

    25. 12-7221-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 12-7221-82, RRID:AB_10597428)

      Curator: @abever99

      SciCrunch record: RRID:AB_10597428


      What is this?

    26. 11-1031-82

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (Thermo Fisher Scientific Cat# 11-1031-82, RRID:AB_465176)

      Curator: @abever99

      SciCrunch record: RRID:AB_465176


      What is this?

    27. 506908

      DOI: 10.1016/j.anaerobe.2024.102859

      Resource: (BioLegend Cat# 506907, RRID:AB_536009)

      Curator: @abever99

      SciCrunch record: RRID:AB_536009


      What is this?

    1. FBst0066687

      DOI: 10.7554/eLife.89795

      Resource: (BDSC Cat# 66687,RRID:BDSC_66687)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_66687


      What is this?

    2. FBst0006596

      DOI: 10.7554/eLife.89795

      Resource: (BDSC Cat# 6596,RRID:BDSC_6596)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_6596


      What is this?

    3. BDSC: 3605

      DOI: 10.7554/eLife.89795

      Resource: (BDSC Cat# 3605,RRID:BDSC_3605)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_3605


      What is this?

    1. AbcamCat# ab4642; RRID:AB_304550

      DOI: 10.1016/j.molcel.2024.03.029

      Resource: (Abcam Cat# ab4642, RRID:AB_304550)

      Curator: @abever99

      SciCrunch record: RRID:AB_304550


      What is this?

    1. AP132P, Merck Millipore

      DOI: 10.1016/j.mcn.2024.103935

      Resource: (Millipore Cat# AP132P, RRID:AB_90264)

      Curator: @abever99

      SciCrunch record: RRID:AB_90264


      What is this?

    2. PA5-86501, ThermoFisher Scientific

      DOI: 10.1016/j.mcn.2024.103935

      Resource: (Thermo Fisher Scientific Cat# PA5-86501, RRID:AB_2803278)

      Curator: @abever99

      SciCrunch record: RRID:AB_2803278


      What is this?

    3. PA5-115016, ThermoFisher

      DOI: 10.1016/j.mcn.2024.103935

      Resource: AB_2899652

      Curator: @abever99

      SciCrunch record: RRID:AB_2899652


      What is this?

    1. Bloomington Drosophila Stock Center

      DOI: 10.7554/eLife.86381

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    2. 60318

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 60318,RRID:BDSC_60318)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_60318


      What is this?

    3. 69158

      DOI: 10.7554/eLife.86381

      Resource: BDSC_69158

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_69158


      What is this?

    4. 68537

      DOI: 10.7554/eLife.86381

      Resource: RRID:BDSC_68537

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_68537


      What is this?

    5. 91403

      DOI: 10.7554/eLife.86381

      Resource: RRID:BDSC_91403

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_91403


      What is this?

    6. 91402

      DOI: 10.7554/eLife.86381

      Resource: RRID:BDSC_91402

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_91402


      What is this?

    7. 84674

      DOI: 10.7554/eLife.86381

      Resource: RRID:BDSC_84674

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_84674


      What is this?

    8. 51981

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 51981,RRID:BDSC_51981)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_51981


      What is this?

    9. 84630

      DOI: 10.7554/eLife.86381

      Resource: RRID:BDSC_84630

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_84630


      What is this?

    10. 51980

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 51980,RRID:BDSC_51980)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_51980


      What is this?

    11. 25685

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 25685,RRID:BDSC_25685)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_25685


      What is this?

    12. 25686

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 25686,RRID:BDSC_25686)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_25686


      What is this?

    13. 25373

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 25373,RRID:BDSC_25373)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_25373


      What is this?

    14. 6874

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 6874,RRID:BDSC_6874)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_6874


      What is this?

    15. 56539

      DOI: 10.7554/eLife.86381

      Resource: BDSC_56539

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_56539


      What is this?

    16. 39016

      DOI: 10.7554/eLife.86381

      Resource: RRID:BDSC_39016

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_39016


      What is this?

    17. 84539

      DOI: 10.7554/eLife.86381

      Resource: RRID:BDSC_84539

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_84539


      What is this?

    18. 31603

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 31603,RRID:BDSC_31603)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_31603


      What is this?

    19. 84614

      DOI: 10.7554/eLife.86381

      Resource: BDSC_84614

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_84614


      What is this?

    20. 24927

      DOI: 10.7554/eLife.86381

      Resource: BDSC_24927

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_24927


      What is this?

    21. 8555

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 8555,RRID:BDSC_8555)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_8555


      What is this?

    22. 92253

      DOI: 10.7554/eLife.86381

      Resource: RRID:BDSC_92253

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_92253


      What is this?

    23. 3605

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 3605,RRID:BDSC_3605)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_3605


      What is this?

    24. 84618

      DOI: 10.7554/eLife.86381

      Resource: RRID:BDSC_84618

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_84618


      What is this?

    25. 60317

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 60317,RRID:BDSC_60317)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_60317


      What is this?

    26. 84540

      DOI: 10.7554/eLife.86381

      Resource: BDSC_84540

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_84540


      What is this?

    27. 2051

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 2051,RRID:BDSC_2051)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_2051


      What is this?

    28. 60028

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 60028,RRID:BDSC_60028)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_60028


      What is this?

    29. 35785

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 35785,RRID:BDSC_35785)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_35785


      What is this?

    30. 5

      DOI: 10.7554/eLife.86381

      Resource: (BDSC Cat# 5,RRID:BDSC_5)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_5


      What is this?

    1. Invitrogen, cat. no. A11030

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: (Molecular Probes Cat# A-11030, RRID:AB_144695)

      Curator: @abever99

      SciCrunch record: RRID:AB_144695


      What is this?

    2. Invitrogen, cat. no. A11034

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: (Thermo Fisher Scientific Cat# A-11034, RRID:AB_2576217)

      Curator: @abever99

      SciCrunch record: RRID:AB_2576217


      What is this?

    3. Abcam, cat. no. ab150157

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: (Abcam Cat# ab150157, RRID:AB_2722511)

      Curator: @abever99

      SciCrunch record: RRID:AB_2722511


      What is this?

    4. Thermo Fisher Scientific, cat. no. 31458

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: (Thermo Fisher Scientific Cat# MA5-31458, RRID:AB_2787090)

      Curator: @abever99

      SciCrunch record: RRID:AB_2787090


      What is this?

    5. Invitrogen, cat. no. PA5102527

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: (Thermo Fisher Scientific Cat# PA5-102527, RRID:AB_2851929)

      Curator: @abever99

      SciCrunch record: RRID:AB_2851929


      What is this?

    6. Santa Cruz, cat. no. sc-98

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: (Santa Cruz Biotechnology Cat# sc-98, RRID:AB_628085)

      Curator: @abever99

      SciCrunch record: RRID:AB_628085


      What is this?

    7. Cell Signaling, cat. no. 2775

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: (Cell Signaling Technology Cat# 2775, RRID:AB_915950)

      Curator: @abever99

      SciCrunch record: RRID:AB_915950


      What is this?

    8. Cell Signaling, cat. no. 5057

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: (Cell Signaling Technology Cat# 5057, RRID:AB_10694076)

      Curator: @abever99

      SciCrunch record: RRID:AB_10694076


      What is this?

    9. Thermo Fisher Scientific, cat. no. PA1–987

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: (Thermo Fisher Scientific Cat# PA1-987, RRID:AB_2107311)

      Curator: @abever99

      SciCrunch record: RRID:AB_2107311


      What is this?

    10. Abcam, cat. no. ab6160

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: (Abcam Cat# ab6160, RRID:AB_305328)

      Curator: @abever99

      SciCrunch record: RRID:AB_305328


      What is this?

    11. Thermo Fisher Scientific 703252

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: AB_2762381

      Curator: @abever99

      SciCrunch record: RRID:AB_2762381


      What is this?

    12. MBL, cat no D139–3

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: (MBL International Cat# D139-3, RRID:AB_592650)

      Curator: @abever99

      SciCrunch record: RRID:AB_592650


      What is this?

    13. Abnova, cat. no. MAB2094

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: AB_1674665

      Curator: @abever99

      SciCrunch record: RRID:AB_1674665


      What is this?

    14. Santa Cruz, cat. no. sc-459

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: (Santa Cruz Biotechnology Cat# sc-459, RRID:AB_631586)

      Curator: @abever99

      SciCrunch record: RRID:AB_631586


      What is this?

    15. Genscript, cat. no. A00186

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: (GenScript Cat# A00186, RRID:AB_914704)

      Curator: @abever99

      SciCrunch record: RRID:AB_914704


      What is this?

    16. Addgene # 31783

      DOI: 10.1016/j.bbamcr.2024.119743

      Resource: Addgene_31783

      Curator: @abever99

      SciCrunch record: RRID:Addgene_31783


      What is this?

    1. Cell Signaling Technology cat # 4082

      DOI: 10.1016/j.scr.2024.103436

      Resource: (Cell Signaling Technology Cat# 4082, RRID:AB_10626776)

      Curator: @abever99

      SciCrunch record: RRID:AB_10626776


      What is this?

    1. 80574

      DOI: 10.3390/ijms242417314

      Resource: (BDSC Cat# 80574,RRID:BDSC_80574)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_80574


      What is this?

    2. 3605

      DOI: 10.3390/ijms242417314

      Resource: (BDSC Cat# 3605,RRID:BDSC_3605)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_3605


      What is this?

    3. 36916

      DOI: 10.3390/ijms242417314

      Resource: RRID:BDSC_36916

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_36916


      What is this?

    4. 29563

      DOI: 10.3390/ijms242417314

      Resource: (BDSC Cat# 29563,RRID:BDSC_29563)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_29563


      What is this?

    5. 33703

      DOI: 10.3390/ijms242417314

      Resource: RRID:BDSC_33703

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_33703


      What is this?

    6. 31902

      DOI: 10.3390/ijms242417314

      Resource: (BDSC Cat# 31902,RRID:BDSC_31902)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_31902


      What is this?

    7. 40931

      DOI: 10.3390/ijms242417314

      Resource: RRID:BDSC_40931

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_40931


      What is this?

    8. ID 33704

      DOI: 10.3390/ijms242417314

      Resource: RRID:BDSC_33704

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_33704


      What is this?

    9. Bloomington Drosophila Stock Center

      DOI: 10.3390/ijms242417314

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    1. BDSC #51323

      DOI: 10.1016/j.jbc.2023.105544

      Resource: (BDSC Cat# 51323,RRID:BDSC_51323)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_51323


      What is this?

    2. BDSC #1521

      DOI: 10.1016/j.jbc.2023.105544

      Resource: (BDSC Cat# 1521,RRID:BDSC_1521)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_1521


      What is this?

    3. BDSC #8860

      DOI: 10.1016/j.jbc.2023.105544

      Resource: (BDSC Cat# 8860,RRID:BDSC_8860)

      Curator: @maulamb

      SciCrunch record: RRID:BDSC_8860


      What is this?

    4. Bloomington Drosophila Stock Center

      DOI: 10.1016/j.jbc.2023.105544

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    1. Cell Signaling TechnologyCatalog: 4650

      DOI: 10.1016/j.xcrm.2024.101547

      Resource: (Cell Signaling Technology Cat# 4650, RRID:AB_10559207)

      Curator: @abever99

      SciCrunch record: RRID:AB_10559207


      What is this?

    2. Cell Signaling TechnologyCatalog: 4376

      DOI: 10.1016/j.xcrm.2024.101547

      Resource: (Cell Signaling Technology Cat# 4376, RRID:AB_331772)

      Curator: @abever99

      SciCrunch record: RRID:AB_331772


      What is this?

    3. Cell Signaling TechnologyCatalog: 9102

      DOI: 10.1016/j.xcrm.2024.101547

      Resource: (Cell Signaling Technology Cat# 9102, RRID:AB_330744)

      Curator: @abever99

      SciCrunch record: RRID:AB_330744


      What is this?

    4. Cell Signaling TechnologyCatalog: 9271

      DOI: 10.1016/j.xcrm.2024.101547

      Resource: (Cell Signaling Technology Cat# 9271, RRID:AB_329825)

      Curator: @abever99

      SciCrunch record: RRID:AB_329825


      What is this?

    5. Cell Signaling TechnologyCatalog: 9272

      DOI: 10.1016/j.xcrm.2024.101547

      Resource: (Cell Signaling Technology Cat# 9272, RRID:AB_329827)

      Curator: @abever99

      SciCrunch record: RRID:AB_329827


      What is this?

    1. Bloomington Drosophila Stock Center

      DOI: 10.1038/s41598-023-49241-8

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    2. w*; PBac{w+mC = UAS-Abeta.1-42}VK00033

      DOI: 10.1038/s41598-023-49241-8

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    3. w*; M{3xP3-RFP.attP}ZH-86Fb

      DOI: 10.1038/s41598-023-49241-8

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?

    4. y1 M{RFP3xP3.PB GFPE.3xP3 = vas-int.Dm}ZH-2A

      DOI: 10.1038/s41598-023-49241-8

      Resource: Bloomington Drosophila Stock Center (RRID:SCR_006457)

      Curator: @maulamb

      SciCrunch record: RRID:SCR_006457


      What is this?